This brand name is authorized in United States.
The drug BAFIERTAM contains one active pharmaceutical ingredient (API):
1
|
Monomethyl fumarate
UNII
45IUB1PX8R - MONOMETHYL FUMARATE
|
|
Monomethyl fumarate is an unsaturated monomethyl ester indicated for the treatment of relapsing forms of multiple sclerosis (MS), to include clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease, in adults. |
Below package inserts are available for further reading:
| Document | Type | Information Source | |
|---|---|---|---|
| BAFIERTAM Capsule | MPI, US: SPL/PLR | FDA, National Drug Code (US) |
This drug has been assigned below unique identifiers within the countries it is being marketed:
| Country | Identification scheme | Identifier(s) |
|---|---|---|
| US | FDA, National Drug Code | 69387-001 |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.